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terminal events, mm do tbey cousider ooiqne aspeds of arrbytb- Cd. We propose a dehptive dossi6catiou scheme 
da investigation a new dassikatiou scheme tbat addresses tbat1)fuuydescribesaadtabutatesansigo&aataspectsof 
tbeae issws is desirable. termtnal wentq 2) irKqm&s prwiMsly ased cautions 
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itored b no or uuknowu]); 4) operative rdatioa (preopemtiv~ (J Am Cd GUM 1996;27:433-42) 
pedopemtive or postoperative); aud 5) system rektiou (procedure 
r&ted,pulsegewratorretatedaudleadreb&dlygaoor 
unkamI). 
Surgical, pharmacologic and device interventions are all corn- of the event. However, even the definition of -‘sudden death” 
manly used for the treatment of arrhythmias. For the protec- has varied from instantaneous lo as long as 24 h from the onset 
don of pa’kents and the proper interpretation of outcome in of symptoms (l-23). Although time-based definitions may use 
clinical trials, adverse events must be documented with acat- death within 1 h of symptom onset as an implication of a 
racy and precision. The ultimate adverse event-death- cardiac arrhythmic cause of death. the time course does not 
requires special attention, and correct classification of its cause neceswily correlate with either the rhythm present at the 
is of vital importance in assessing the efficacy of any antiar- onset of the terminal event or its cause (1-15). Ckmsequently, 
rhythmia therapy. The two most commonly used methods of previously used defmitiorfi are inherently limi&i and often 
class&akm are based on the time course of terminal events inadequate for classi&ng deaths in contemporary eledrw 
and their mechanism. Implicit in most definitions of sudden plydogk elinicd investigations of antiarrh@mia devkes. 
death is its unexpected nature, a cardiovawdar origin and Furthermore, because patients with arrhythmias often have 
occurrence within a short time from the onset of symptoms. other serious medii conditions, the classikation of death in 
Tlms, death has often been classilied solely on the suddenness patients treated for arrhythmias should integrate factorc relat- 
ing to the temporal comw of death with the natural history of 
the disease being treated, competing causes of mortality and 
Front the Divisim cd CardiwPseubr Lkease, Departmerit d Medii. complications of the intervention being tested (24-X). 
Universityd~aatBiiBBmii-‘Divbiood 
car-, Depamaent of hkdicke. case westenl Reave ueiversity, ckw 
Becam no presentiy aaxpte4l dass&atinn of death ad- 
Iatld,ottiitDividanofCardidogy.DepamneatdMedieine.AUegkny dressesalltbeseiwesconeurrentJy,wedese&eaade- 
GenualHo#al,Pimt~nJhPeamylvaaia; tRe&malCardkArrbymmia 
ceoter,saippaMemorialHmpitalLaJoua.catif~attdDDivirind 
!?aiptii classi6eation s&me for death that has the folknving 
cbrdh&g~~d~.LaheyclinicMedieplceater.~m 
advantages: 1) It fulEy descrik and tabulates all significant 
aspectsofterminalevents;2)itbothinaupwW~ 
ManusaiptraetiMayZ1995;dmPrwoptrweivedAuystK used categorizations of death aud olfen new cat- 
199%G%zlx+dseptcmber26 1995. 
Divikmof~ 
tkdaddrestmiqueaspeetsof~~~(e~ 
ltimitystatieu IHT operativemortalityiusturiiesofan~mdevim;d3) 
AIicientdataare~aUowingeomparison~~~ 
073s.HRIRbnisnm 
073sl~arpDIItr- 
434 EPSlEIN ET AL 
Cl..ASSIRCATiON 07 DF.ATH 
studies, both past and future. ::, matter what method was used 
for tabulating the data. The classification scheme was devel- 
oped as the result of discussio.1 that occurred in the context of 
an Events Committee (the authors) that reviewed deaths in 
clinical investigations of implantable delibrillators and pace- 
makers. 
Methods 
Classification of Death: Description and Rationale 
The current scheme recognizes that terminal events cannot 
be adequately described by a simple phrase such as “sudden 
death,” and that nearly all deaths that occur suddenly are 
ultimately associated with arrhythmias (4,6~7,9,10,14,15,17, 
l&21). Other organ system causes, the temporal course of the 
death (which may be unknown) and particular relation to the 
intervention being tested are all recognized as important. 
Thus, five categories are defined and used to classify each 
death: the primary organ cause of death, the temporal course 
of death, documentation of the terminal event, its operative 
relation, and its relation to the arrhythmia intervention being 
studied. In each section of the classification scheme, an 
unknown category is available because the absence of infor- 
mation is common, and further information is often unobtain- 
able. However, the unknown category is never to be used as a 
mechanism to absolve the investigator from pursuing all avail- 
able avenues to obtain information that may be available 
regarding a patient’s death. 
Rhoay nrgan cause. Because this classification is de- 
signed to be used for classifying deaths in patients treated for 
cardiac arrhythmias, a major distinction to be made is whether 
deaths are due to cardiac or noncardiac causes (Table 1). 
Primary organ cause refers to the organ system that precipi- 
tated the event that led to death. Deaths classified as cardiac or 
nonc&ac must be accompanied by data that support the 
asserted organ class~tion. Deaths that are not accompanied 
by data that conkrn a responsible organ system, or deaths in 
which the data are amtradictory, are class&d as unknown 
Cardiac deaths are subclassitied as ar$thmik, noMnfryhmic 
or unknown Documentation of the rhythm (by monitoring) is, 
of course, always desirable. Thus, when pos&le, ar&ythmic 
deaths are further subclassi6ed (see Documentation of the 
terminal event, discussed later). The cardiac, wknown cate- 
gory is used only when it is impossible to determine with 
reasonable certainty whether a cardiac death was primarily due 
toanarrhy&&ormMerrhythmiccause. 
‘In clii device investii\ions, ail unknown deaths can be 
analyzed for regulatory pmposes as arrhythmic cardiac deaths 
to minimize underreporoing. The unknown category is used 
onlyifcinwnstancesrnaketheassignmentof~death 
more tmcertain. For example, consider a patient who dii after 
~~~~of~~~~~ate~t~ 
erative period after insertion of an implantable cardioverter- 
deihiktor. A pulmonmy embltss, cardiac perforation or 
~are~~~e~~~~~~~o~n 
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T&k 1. Classltication Scheme 
I. Primary organ cause 
A. Cardiac 
I. Arrhythmic 
2. Nonnnhythmic 
3. Unknown 
B. Noncardiac 
c. unknown 
II. Temporal course 
A. Sudden 
B. Nonsudden 
C. Unknown 
III. Documentation 
A. Wilnesszd 
1. Yes 
2. No 
3. Unknoln 
B. Monitored 
1. Yes 
a. Ventricular tachyanhythmia 
h. Bradyarrhythmia @us hradycardia, high degree 
atrioventricular biock with slow ventricular response, asstole) 
c. Electromechanical dissociatkm 
d. Other (sinus rhythm or supraventricular tachycxdia including 
atrial !ihrillation or flutter with ventricular qxmse 60-100 
beatslmin) 
e. Unkoown 
2. No 
3. Unknown 
IV. Operative relation 
A preoperative 
B. Perioperative 
C. Postoperative 
V. System relation 
A. Procedure related 
I. Yes 
2. No 
3. Unknown 
B. Pulse generator related 
1. Yes 
2. No 
3. unknmvn 
C. Lead(s) related 
1. Yes 
2. No 
3. Unknown 
cause of such a death would be classili~~ as unknown, unless 
there was anatomic documentation to explain the event, such 
as found at autopsy, or radiographic or other documentation of 
a pulmonary embolus or cardiac perforation. The usefulness 
and importance of an autopsy cannot be overstated. Consider 
a second ezkmple of a patient admitted to the hos$tal for 
progressive heart failure ending in death. In this instance, the 
phnary cause Gould be can&c, MMnhyrhmic (i.e., heart 
failure) even though an arrhythmia may have been the termi- 
nal event. Indeed, every death, whether due to a cardiac or 
noncardk cause, is ultimateiy @ted with either ventric- 
ular fibrillation or asystole. it’is important to reeognk that the 
final alnuuon pathway for all deaths is kadyca& (asystole), 
whkbmayormaynothavebeenprece&dbyaventricuk 
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arrhythmia. Thus, our intent is to use the cardiac, nonarrhyth- 
mic classification when the patient’s clinical status is unstable 
before the terminal event. Furthermore, it is appreciated that 
many of these patients have chronic symptoms and that it is 
often exceedingly difficult to determine a precise time of 
symptom onset and the point in time that separates the 
continuum of chronic symptoms from the terminal event. 
In the present classification, the organ system responsible 
for an ilhtess that leads to death is classified as the cause of 
death. Unlike other categories in our classification scheme, the 
primary organ cause may reference an earlier time in the 
patient’s clinical history than the immediate time of death. 
Current in-hospital electrocardiographic (ECG) telemetry and 
out-of-hospital monitoring systems have allowed increased 
documentation of these arrhythmias. In some cases, arrhyth- 
mias are a cause of death; in others, arrhythmias are the result 
of a pathologic process (cardiac or noncardiac) that is the 
cause of death. The proposed system accounts for this problem 
by separating the classification of organ cause from the classi- 
fication of arrhythmia at the time oi death. Thus, the death of 
a person who hd a cardiac arrest and who was resuscitated, 
onfy to die weeks later, never awakening from a coma, would 
be classified as a caniiac ahythmic, sudden a’eash Further- 
more, the classification scheme allows deaths tn. e cl ssitied as 
cardiac, mnarrhyhmic even when an arrhytL.tia is docu- 
mented at the moment of death. Thus, if a patient is admitted 
with a myocardial infarction, develops cardiogenic shock and 
dies the next day, the cause of death is classified as cardiac, 
nonarrhythmii, even though he or she may have experienced 
ventricular tachycardia at the time of death. This system 
recognizes that the event precipitating the hospital admission 
and final event is an important component of the death 
classification. 
Tempalaf course of death. Definitions of sudden death 
have classically incorporated a variety of criteria. Instanta- 
neous, within 1 h of the onset of symptoms and within 24 h of 
the onset of symptoms have been used to define sudden (l-23). 
A precise determination of the exact time when a fatal event 
starts may be obscure because many patients have chronic 
symptoms (e.g., from ischemia or congestive heart faihrre) for 
months or years before their terniinal event. Thus, the folhnv- 
ing definitions are proposed with the intent that they will 
ahow not only for the accumulation of new data, but also 
for comparison with data acquired in previous studies (5.6, 
9,lOJS). S&&n dmth is defined as death that occurs 11 h 
after the onset of symptoms, if a sudden change in symptoms 
can he defined. A death that occurs after prokmged resuscita- 
tive efforts (lasting > 1 h) is also @&tied as sudden. Nwwd- 
den dtah is death that occurs >l h after the onset of 
symptorns’fireu&oivncategoryisusedwhenthepatientis 
found dead and had not been seen for >I h. The unknown 
category is useful because it allows deaths that occur within 1 h 
aftertheonsetofsympWmstobeseparatedfromunwftnemed 
deathsthat,insomepmviousdassi~hadbeencalled 
sudden or %rrhy&mic~ just because the patient was found 
dead and no other i&ma&n was ava’hrble. Fu&ermoz, if 
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in a ciinicai trial a large number of deaths are classified as 
unknown, study monitors should encourage investigators to 
pursue documentation aggressivety for the event be!ng exam- 
ined. The unknown category can be combined with the sudden 
category for studies that assume a “worst case scenario” (i.e., 
all unwitnessed deaths are sudden). 
Documentation of termhmf event. This category contains 
witnessed and monitored subcategories, which are indepen- 
dently recorded. In keeping with previously described classifi- 
cation schemes, the titmsed category is designed to deter- 
mine whether or not the death was actually observed. Options 
for classification in this category are yes, no or unknown. An 
affirmative response requires that an alert witness be physically 
present in the same room as the patient at the time of the onset 
of the symptom(s) that subsequently led to death. The only 
exception is a monitored patient in the hospital (see later 
discussion) whose death is considered witnessed regardless of 
whether its onset was attended. Thus, the death of a patient 
whose spouse awakens to find him or her dead is classified as 
u&tread because, even though the two were in the room 
together, dassihcation as witnessed requires the witness to be 
alert at the time of death. 
The documentation category is also used to gather infor- 
mation about the circumstances surrounding the terminal 
event, particularly as to whether the rhythm was or ws not 
monilond Because terminal events can transpire over ex- 
tended periods, it is required that the patient be monitored at 
the onset of the symptc7-i. !eading to death for an afhrmative 
response to be entered in this field. For example, the rhythm of 
the patient who devflops ;re:errninal symptoms resulting in 
an ambulance call is class~t;d as umnonitored because the 
symptoms started before emergency medical personnel tirst 
monitored the rhythm. An event class&d as monitored is 
subdmi6ed into the actual rhythm documented: ventricular 
tachyarrhythmia, bradyarrhythmia, electromechanical dissoci- 
ation, other or unknown. The rhythm interpretation offered by 
a competent observer is accepted for the monitored categori- 
zation. The unknown subcategory is used when the terminai 
rhythm is monitored but a&able records prohibit proper 
dassi6eation. In ctinical trials of new antiarr+@mii devises, 
however, it is inapproptiats to use stored ew or other 
information (such as RR intervals) stored in the device under 
investigation to assist in the evahration of that devi& func- 
tion.Thisinforma~evenifavaif+r,isignoredintriak 
testingtheefficacyofnewimjrlantabledevices.Itmaybe 
appropriately used when an antianhythmic drug, a new im- 
pkmtable ca&overterdefibriMor (ICD) tead (hut not the 
generator) or a separate pacemaker is the treatment being 
invest&ted However, even ICD e&&ogmms may have first- 
itedvaluebecausetheycaptureodybriefwindclaaiotkW,aml 
theonsetoftheinitiafanhyU&amaynothaveheenrecmded 
ormayhavebeenovefwrittenifmuitipfeanllythmiaswere 
detected.Furthermore,theyteUitsnothingahoutthedinicaf 
eventsthatmaygiveduesaboutthemechm&mofdeatfasoch 
afdBtdi%W&&cfyspnea~ECGcb2mga~ 
isdlemiaormyocanfial- 
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OPer&ve reIatlon. The classifications in this’category are 
preoperative, perioperative and postoperative. Deaths that 
ofcu~ after informed consent has been signed but before the 
intervention has been implemented (e.g., an operation to 
implant an ICD) are classitied aspreope~fr~ Tbepetio~rarive 
period extends from the onset of operation (administration of 
anesthesia) to 39 days postoperatively, or until the time of 
hospital discharge, whichever is longer. Death that occurs in a 
ski&d nursing facility >30 days postoperatively is classified as 
a perioperative death if the patient had not been discharged 
from a medical facility in the interim, unless the patient had 
lived in such a facility before admission. The posfoperafive 
period extends from the perioperative period until the time of 
death. However, if a patient requires reoperation, the 30day 
perioperative clock starts again. 
Although the times of death are compartmentalized into 
three discrete time windows, the time to death can also be 
treated as a continuous variable beginning with the time that a 
decision for intervention is made or when the operation is 
undertaken. In a clinical trial, this point may be the moment at 
which the informed consent is signed. If the exact dates when 
treatment begins and when death occurs are recorded, actuar- 
ial survival and hazard analyses of mortal and morbid events 
(which are ideal methods to compare outa+ne in prospective 
trials) can be undertake 0. 
System reMon. Deaths that may b- ArIated to ICD system 
problems or malfunction are of great importance in clinical 
trials assessing the safety and efficacy of devices. In the 
proposed classihcation scheme, system-related deaths are di- 
vided into three categories: procedure related puke generator 
releted and &ad(s) related Options for classification include 
yes, no or unknown. The purpose of separating deaths into 
these three categories is to distinguish between those deaths 
related to hardware malfunctions from those related to the use 
of the hardware. Roth problems are important to identify, but 
have ditferent implicatiins. 
pmcedure-relared deaths include those secondary to any 
perioperative or postoperative complication (at initial implan- 
tation or subsequent revision of the system), such as pneumo- 
nia, pneumothomx, pulmonary embolism, congestive heart 
faihne, myoc~~niii infarction refractory ventricular arrhyth- 
mias (9entricuiar tacbycardia storm”), system infection or 
stroke. These deaths are a result of the procedure required to 
implant the system. Most perioperative deaths are thus classi- 
lied as procedure related. A death during kidney transplanta- 
tion within the 3tMay postoperative period would be a peri- 
opemtive death, but not procedure related (assuming that the 
kidney failure WAS not the result 01 compli&ons related to the 
device surgery). In this system relation category, deaths occur- 
ring >30 days postoperatively are also subject to classiftcation 
a3 pmcedure related. 
User-devix interactions resulting in death are considered 
procedure related. These deaths would prima@ be the con- 
SeguemX of programming sele&ms inappropriate for a given 
ciinbd CinumstaMp or patient. The “user” may be a physi- 
c& tmSe, tehician or even the patient or far&y member 
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(who inadvertently disabled an ICD with a magnet). An 
example of such a problem would be a case where program- 
ming of the pulse generator allowed for prolonged, less 
aggressive or ineffective treatment before defibrillation. An- 
other’example would be programming the first defibrillation 
shock of an ICD below the defibrillation threshold energy. If a 
physician forgets to insert a set-SC&v in an ICD header, this 
also would be considered procedure related. Classifications in 
this category are obviously subject to interpretation. 
The pulse generator-related category is reserved for deaths 
related to device malfunction. Evidence of malfunction would 
include postmortem bench analysis as well as witnessed events 
before or at the time of death during which inappropriate 
device function is observed. If it is unclear that therapy was 
administered, or that therapy was administered without success 
and the device is ..x available for analysis, pulse generator 
involvement in the death is classified as unknown. 
Likewise, the lead(s)-related category would be marked 
‘yes” only for lead hardware failures, including insulation or 
conductor problems. Similar to the pulse generator-related 
category, if the death is sudden or temporally unknown, or 
witnessed therapy is ineffective, the death would be classified 
as unknown. Cardiac perforation and lead dislodgment are 
procedure-related, not !ead(s)-related, events, unless there is 
evidence for failure of the leads that led to these complica- 
tions. For both the device-related and lead(s)-related catego- 
ries, when there is no indication of malfunction, the classifica- 
tion is “no.” 
Results 
The following case histories are abstracted from those 
reviewed by the authors’ Events Committee; they illustrate 
how the proposed scheme can clarify the cla.Gfication of death 
in difficult cases and assist in performing meaningful outcome 
analyses (Table 2). Each of the patients was in a clinical trial 
sponsored by a manufacturer of pacemakers and ICI% (Car- 
diac Pacemakers, Inc.) and gave written informed consent 
before receiving their investigational device. Each participat- 
ing center received approval for the investigations included in 
this review from their respective Institutional Review Boards. 
Jhampk 1. The wife of a patient observed her husband 
slump over in his chair and receive multiple shocks from his 
chronically implanted ICD. Subsequently, ventricular fibrilla- 
tion was documented by paramedics, but the patient could not 
be resuscitated. Device interrogation showed ventricular fibril- 
lation as the rhythm before the first shock. This death is 
classified as a witnessed cardiac anhythmii death that was 
unmonitored because there had been no monitoring h&pen-, 
dent of the ICD being investigated. Although primary ventric- 
ular fibrillation is suspected to have caused this arrhythmic 
death, there is no evidence to exclude other primary arrhyth- 
mias, such as a bradyarrbythmia that degenerate+ into ventric- 
ular fibrillation. Although the event was not procedure related, 
device and lead relations are classified as unknown because 
there was MWXIW&M. 
JACC Vol. 21. No. 2 EPSTEIN ET AL 
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Table 2. kxamples of Classification 
Patient Number 
1 2 3 4 5 6 7 8 9 IO 
1. Primmy organ cause 
h Cardiac Y N Y N N Y N Y Y N 
I. Anhylhmic Y Y Y N N 
2. Nonanhythmic N N N Y Y 
3. UnloKmvn N N N N N 
B. Noncardiac N N N Y N N N N N N 
c. uoknom N Y N N Y N Y N N Y 
II. Temporal course 
h Sodden Y Y iv N Y Y N N N N 
B. hkmsuddeo N N Y Y x N N Y Y N 
c. UnLncm N N N N N Y Y N N Y 
111. L?ocumentation 
A. Witnessed Y Y Y 1 Y Y N Y ii N 
B. Monitored (rbylhm if monitored) N N Y CM) y W) Y IBrf Y (VT1 Pi u N N 
IV. Opra+ve relation 
h PItoperative N N N N N N N ?j N N 
B. Perioperative N N Y N N R N Y Y N 
c. Postoperative Y Y N Y Y Y Y N h Y 
V. Sysem relation 
h Procedure related N 1 Y u N Y U Y Y N 
B. Pulse generator related U U u N u N U u N Ll 
C. Lead related u u U N U N u U N u 
BI = bmdyanhytbmii N = no; U = unkwwn; VT = ventricular tacbycda; Y = yes 
Example 2. Four months after receiving an ICD for resus- 
citated cardiac arrest, the patient complained of dizziness, lost 
consciousness and received several shocks without subsequent 
revival. After the paramedics arrived, the patient was pro- 
nounced ead and transported to a morgue without the device 
having been retrieved. This sudden death is categorized as 
witnessed, unmonitored and postoperative. However, and in 
contrast to the first example in which there was relatively more 
information available, the unknown designation is used for the 
primary organ cause because, although an arrhytbmii cause is 
suspected, a  cardiac cause seems less certain. Similarly, the 
generator-related and leads-related categories are also classi- 
fied as unknown because apparently there had been unsuccess- 
ful shock delivery. There is no relation to tbe implantation 
procedure. 
Example 3. A patient with an ischemic ardiomyopathy 
remained in the hospital after implantation of an ICD as a 
result of multiple episodes of ventricuku tacbycardia that were 
terminated by appropriate ICD shocks He worsened, dcvei- 
oping progressive and intractable heart failure, a  low output 
state and hypotension. Over several days, obguria and encepb- 
alopathy ensued, followed by ventricular tafhycardia, multiple 
ICD and external shocks and tinally death. Tbii nons&den 
arrhythmic death is ChIssified as witnessed, monitored and 
perioperative. It is considered arrhythmic because ventricular 
t-i initiated the terminal course of events, and proce- 
durerefatedbecauseitoccmredduringtbebospitafperiod 
~~~~~~~lt~~~~ 
thedeatbwasr&atedtopulsegetleratororleaddysfugction 
because there were documented episodes of nonconversion 
when the patient died. 
Example 4. A patient was admitted with signs and symp 
toms of a  pulmonary embolism 6weeks after transvenous ICD 
system impfanration. A puhnonary arteriogram confirmed the 
diagnosis. Three days later a  cardiac monitor doctmrented 
ventricular tachycardia and appropriate ICD shocks followed 
hy electrcmechanical dissociation, asrole and death This is 
considered a noncardiac, non&den, witnessed (because it was 
monitored in-hospitat), postoperative d ath. in this example, a  
ventricular tachyar&&mia was documented, but the death is 
not considered arrhythmic because tbe presenting p4hnotq 
embolus was judged to have been of great enough clii 
signiiicance to have resulted in the sequence of events that led 
to the terminal event. The relation to the implantation proce- 
dureisun&nownbecausetbeembolismmayhaveariseafmm 
the ICD lead. 
Esampk 5. A patient with ischemic heart disease, periph- 
eral vascular disease and ventricuhu Whycan& treated witb 
amicdaronc and an, ,ICD for 6  months was admitted with 
abdominafpainduetomxroticbowel~thoughttobesecondq 
to an embollus He underwent an extensive bowel resection. A
nursewasfeedingtbepatientandsteppedfromtben3omto 
anawez a page. She returned moments kiter to find the patient 
tmmpomk. Attempts at card+uhnonq resILscitatioIL were 
umuccessfulMoaitorstripsattheonsetoftbeeventshcmeda 
suddeniossofcardmcactivityandonfyventrimdarpacktg 
artihcBwitixnltcaphne.TlIedeathactassifiwasas 
monitoredandduetoa~evenLXbeprkmuyorgtn 
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cause is unknown. Although not procedure related, it is 
unknown whether there was a pulse generator- or lead-related 
problem because there was evidence of pacing without capture. 
This example highlights a case of sudden death that was clearly 
not related to a ventricular tachyarrhythmia. 
Example 6. A patient with severe heart failure, an ejection 
fraction of 0.10 and sustained ventricular tachycardia received 
an ICD capable of antitachycardia pacing. The device was 
programmed for multiple antitachycardia pacing attempts be- 
fore cardioversion in the “ventricular tachycardia zone,” which 
was extended to 250 beats/min. The total time to the first 
defibrillation shock, if all the other programmed therapies 
were delivered, was anticipated to be 2.5 min, and the “time 
out” was extended to allow for this to occur. After complaining 
of palpitations, an ambulatory monitor was provided. While 
talking to his family, the patient described palpitations like 
those he had with ventricular tachycardia, and then he died. It 
was determined later from the ambulatory monitor that the full 
treatment scheme had been dehvered without success. On 
bench analysis, the lead and generator were found to be 
“within specifications” on completion of returned product 
analysis. The death was classified as a sudden, arrhythmic 
cardiac death that was procedure related because program- 
ming may have resulted in delay to definitive therapy, and the 
programming error could have been anticipated. It was not 
related to the pulse generator or leads. This example features 
use of the classification system in cases where the role of ICD 
programming is in question. 
zures ensued and a computed tomographic scan showed 
cerebral edema. Because of the poor chance for neurologic 
recovery. a decision was made not to resuscitate the patient, 
and he died after being taken of the ventilator. This death is 
classified as cardiac (precipitated by hypotension) but nonar- 
rhythmic (because of the myriad of o!her medical problems), 
nonsudden, witnessed (patient taken off the ventilator) and 
perioperativc. Although one may presume that the death was 
monitored, there was no documentation, and the monitoring 
status was classified as unknown. The death was further 
categorized a5 procedure related, and it is unknown whether 
the leads or pulse g&nerator were involved (e.g., lead perfora- 
tion, %+Cgmcni causing more frequent arrhythmias). 
Example 9. An elderly patient with coronary artery disease 
and amiodarone pulmonary toxicity received an ICD system. 
The hospital course was complicated by a low cardiac output 
state, ileus, sepsis (Staphylococcus epiderminis) and recurrent 
ventricular tachycardia. A decision was made not to make 
turther resuscitative attempts, and the patient was found dead 
in his hospital bed. This death is classified as cardiac nonar- 
rhythmic, nonsudden, unwitnessed, unmonitored and periop- 
erative. Because the death occurred during the initial hospital 
period, and because there was sepsis, it was considered proce- 
dure related. However, because multiple episodes of ventric- 
ular tachycardia were terminated by the system, there is no 
indication that there was a relation to the pulse generator or 
leads. 
Example 7. The patient had an ICD system for 4 months. 
The investigational center was notified after the patient’s death 
that he had been admitted to a noninvestigational hospital for 
a pulmonary embolus and was found dead in bed one morning. 
The investigator indicated that he was unable to obtain any 
other information. Tbe primary organ cause is unknown 
because in the absence of additional data, it is impossible to 
have any degree of certainty regarding whether the death was 
due to a cardiac or noncardiac cause. Indeed, documentation 
for a pulmonaty embolus was not even available. Because the 
patient was found dead in bed, the death was classified as 
unmonitored and unwitnessed. The temporal course was clas- 
sified as unknown. Furthermore, all system relation categories 
were classified as unknown be&use there were no data in the 
short summary regarding device function. 
Example 8. The patient had a hypertrophic cardiomyopa- 
thy (ejection fraction of 0.20), atrial fibrillation and ventricular 
tachycardia. Sinus rhythm was restored by cardioversion at the 
time of electrophysiologic study. During therapy with sotalol, a 
transvenous ICD system was implanted. On the day of opera- 
tion, atria1 arrhythmias were observed and !%e ICD shocks 
delivered, but rhythm strips were not record&d. After transient 
treatment with diitiazem and procainamide, amiodarone was 
started On the fourth postoperative day, the patient developed 
hypotension followed by respiratory arrest. Other medica! 
pmblems included a serum potassium of 7.2 m&/liter, right 
Lower k&e pneumonia, shock liver and renal failure r&ces.ji- 
Utin# peritoneal dialysii The patient became obtunm sei- 
Example IO. A patient with an ischemic cardiomyopathy, 
ventricular tachycardia and an investigaiional ICD was found 
dead in bed. The explanted device was interrogated and 
showed multiple successful conversions of ventricular tachy 
cardia, as well as four shocks that were unsuccessful in 
converting ventricular fibrillation. The device was returned to 
the manufacturer and was found to meet specifications. The 
death is classified as primary organ cause unknown, temporal 
course unknown, not witnessed, unmonitored (telemetered 
data from the device being investigated cannot be used for 
classification), postoperative and not pro&Jure related. How- 
ever, the pulse generator-related and lead-related fields are 
classified as unknown because in this clinical investigation it is 
possible that the ICD or lead system failed, contributing to 
what was probably an arrhythmic cardiac death. For the 
purposes of comparison with previously developed databases, 
this death highlights how classifying a death-ss unknown in 
both the organ cause and temporal course categories still 
would allow assignment of the death as car&ac arrhythmic 
when reporting for regulatory purposes. 
Appkation to a clinical his1 The clas&cation scheme 
was applied to a clinical trial of the Model 1625 ICD (Ventak 
P2, Cardiac Pacemakers, Inc.) and submitted to the Food and 
Drug Administration for market approval. The ICD is a 
biphasic device that has the capability to provide low and high 
energy defibril\&ing dnd caaldioverting shocks. bradycardia 
pacing stored electrograms of arrhythmia events and ventric- 
ular fibrillation induction for &vice testing. The system was 
recently approved for market release. ‘I&e final classifiation 
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Table 3. Center-Reported and Events Committee Classification death are used in published reports. usually based on the time 
Bents course of the terminal event. These definitions imply a cardiac 
cenrer Committee arrhythmic cause, and the time course in ;he definitions has 
Categ0ly Classification Classification ranged from “instantaneous” (ranging from 30 set to 5 min) to 
Cardiac 24 h (l-23). Because of inherent errors in this simplified 
Tachyarrhythmic IS 12 classification, the trend has been to assess only total mortality 
Bradyarrhythmic 2 0 in clinical trials. A recent policy conference from the North 
Nonarrhythmic 21 24 American Society of Pacing and Electrophysioloy,, however, 
Noncardiac 31 10 
Unwitnes..d/asumed cardiac IO I’ suggested d reporting scheme incorporating total mortality, 
tachyarrhythmic (unknown in new cardiac mortality and noncardiac mortality. The consensus 
clarification) conference recommended that total mortality should be the 
TOlal 79 m  primary end point for arrhythmia investigations. However, to 
identify therapy-related problems that could be overlooked if 
only total K; eality were reported. device malfunction and 
was arrived at by consensus of the authors serving on an Events complications are also recorded (27). 
Committee for the manufacturer. When there was disagree- Problem of chronic symptoms and defining the onset of 
ment in classification, it was often because one of the reviewers terminal events. Although classifications of sudden death 
overlooked a piece of information in the summary data have lxen based on the temporal course of death, it has 
provided to the committee. become clear that the spectrum of symptoms associated with 
‘I??.: ‘rial included 1,250 patients, 79 of whom died. The death does not correlate with mechanism (8-lZ.‘7~15,21-23). 
investigators’ Events Committee reviewed all deaths, agreed Just as ventricular tachycardia can persist for houn before 
with the investigator death cla&cation in 47 cases and hemodynamic failure and collapse oo(11r. Ir- 5no to the death 
reclassified the remaining 32. The original and final classifica- (the “not so sudden” arrhythmic death of Guamieri et al. [2x]), 
tions using the old criteria are tabulated in Table 3; changes in so too can mechanical dysfunction occur very rapidly, leading 
that classification are shown on Table 4; and the final Events to death within several minutes (a nonarrhythmic sudden 
Committee claGfication is shown in Table 5. death). Thus, a solely time-based definition for classifying 
death as arrhythmic is inherently fragile because symptoms do 
Discussion 
not corre!ate with the etiology of the terminal event. After all. 
asystole is the “terminal” rhythm for all patients at death. The 
In clinical trials, the accurate assessment of treatment frailty of prior definitions of sudden death that rely on the time 
efficacy requires an accurate assignment of end points, whether course of the event is all the more important when treatments 
they be an adverse event or a beneficial treatment effect. For directed at preventing arrhythmic death are subjected IO 
interventions designed to prevent arrhythmic death, usable and clinical investigation. Their efficacy is judged based on out- 
reproducible criteria to describe the circumstances of death come, despite inaccurate classification of the mechanism of 
are mandatory. The proposed classification scheme attempts to death. This inadequacy led us to revise the commonly used 
provide such a classificaiion. classification schemes of morbid events in clinical arrhythmia 
Variable definition of ‘sudden death” based on temporal trials by combining time-base 3 classifications with a mechanis- 
course. ‘Sudden” deaths have classically been assumed to be tic approach. 
“arrhythmic.” Nevertheless. a variety of definitions of sudden Because patients with (: rdiovascular disease often have 
Tat&e 4. Changes From Center-Reported Clacsitication to Events Committee Ciassii ~&XI 
Events Gxxmiuee NC. ni 
Center flassification CI&ication Patirn15 
Cardiac, tachyanhythmic Cardiac. nonsrr*mic 3 
Cardii, tachyanhythmic Unkmn 1 
Cardiac, bradyarrhytbmic Cardiac. wnar+thmic I 
Cardiac, bradyxdqhmic Nwc-xdiac I 
Cardiac, nonanhythmic Unhn 3 
Cardiac, nmwrhythmic Cardiac. txb~arrh~~hmic 3 
Cardiac. nowrhythGc Nnncaldiac I 
Noncardiac Cardiac. nuwmh$hmic 4 
NonCardiaC Ull~fl 0 
U,,&nes&l~d cardiac. tacbyarrhythmic (unknowt) Cardiac. tacbyarr~thmr; I 
UIpu~ cardiac Iz&yamhylbmic (uakn#il) cardiac. norrrrrhyrhmk 1 
Totdl 32 
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Table 5. Final Classification Using Proposed Scheme 
No. of 
Patients 
thought to have had a definite or presumed arrhythmia, and 
11% were thought to have succumbed as a consequence of
circulatory failure. However, in the subsequent 23 h after the 
onset of symptoms, 32% of the deaths were thought o be due 
to shock or heart failure, whereas only 66% were presumed to 
be due to arrhythmia. Thus, early death (within 1 h of the onset 
of symptoms) seems to be dominated by arrhythmias (either 
due to or secondary to acute ischemia or infarction), and late 
death {after 1 h) is due to pump failure with secondary 
arrhythmias. Goldstein (5) proposed that a l-h time limit be 
used to define arrhythmic death. However, in the Cardiac 
Arrhythmia Pilot Study (CAPS), deaths judged to be arrhyth- 
mic did not always occur within 1 h of symptom onset (9,lO). 
Converse!y, some nonarrhythmic deaths appear to have oc- 
curred in less than 1 h after the onset of symptoms. In 27% of 
the classified eaths, the suddenness of onset did not corre- 
spond to the assigned mechanism of the event (arrhythmic or 
nonarrhythmic). Specifically, 9 (31%) of 29 deaths occurring 
within 1 h of symptom onset were classtied as nonarrhythmic, 
and 3 (19%) of 16 deaths occurring after more thaiI 1 h after 
symptom onset were classified as arrhythmic. Thus, as pointed 
out by the CAPS investigators, a time-based efinition, albeit 
simple, is often inaccurate in determining mechanism. 
I. Primaryorgancause 
a cardii 
!. AAythak 
2. Nonarrhythmic 
3. tJnknm 
B. Noncardiac 
c. Unh 
II. Temporal course 
A Sudden 
B. Nonsudden 
c. untnown 
In. rwmnestat.k?!! 
A. Witnessed 
1. Yes 
2. No 
3. Unknown 
B. Monitored 
1. Yes 
a. Ventricular tachyanhythnlla 
b. Bradyanhythmia 
c. Electromechanical disc&&m 
d. Other 
e. unknmn 
2. No 
3. unknovn 
IV. Operative relation 
A. Preopxative 
B. Periopcrative 
c. Postoperative 
V. Syslem relation 
A. Procedure related 
1. Yes 
2. No 
3. UnLnown 
B. Pulse generator elated 
1. Yes 
2. No 
3. unknown 
C. Lead related 
1. Yea 
2. ,No 
3. unknown 
TOtal 
36 
12 
24 
0 
20 
23 
22 
4h 
11 
39 
17 
23 
23 
9 
5 
3 
2 
4 
29 
27 
0 
14 
65 
7 
60 
12 
0 
49 
30 
0 
48 
31 
79 
chronic symptoms, it is often diiult, if not impossible, to 
determine whether the patient’s death is the result of progres- 
sion of chronic symptoms as the underlying cardiac pathology 
worsens, or au event that may have been prevented if effective 
treatment could have been provided. Ftihermore, for defini- 
tia3lsofsuddendeaththatre8ontheonsetofsymptorns,itis 
diili& to ideittify the exact time of the terminal event’s 
“tmsef* when the chrome sytnptoms are present. In the Aspirin 
in Myomdial Infarctioa Study (AMIS), 59% of the witnessed 
deathsoccurredwithialbofsymptomonset(529).Ofthese, 
~~~~~~~~ut~~~73%~~ 
patie4lLLOfthepaticntswhodiedwithin1h,87%were 
In a similar analysis, Ector et al. (30) indicated that in a trial 
of 129 patients with ventricular tachycardia or ventricular 
fibrillation, or both, 6 (26%) of 23 deaths were problematic 
because it was ~Xic~,4t to separate the natural progression of 
underlying severe heart disease from an instantaneous event 
independent of the disease’s natural history. Because brady- 
cardiac deaths may be more common in patients with heart 
failure. classification can be even more problematic (31). 
Indeed, Cohn et al. (32) reported marked interobserver differ- 
ences in classifications of death in studies of heart failure, in 
part due to investigator bias. Pratt et al. (33) recently reported 
that a fourfold variation in sudden cardiac death rates in 
implantable defibrillator trials is possible from the same data 
set depending on baseline assumptions. Although it is essential 
to avoid bias by blinding the investigators classifying events in 
clinical trials that compare treatments, in investigations that 
have no control or comparison groups (for example, premarket 
evaluations of new pacemakers or dettbrillators), blinding is 
not feasible. 
Disoordsere hefween first &lent&l rhythm and rhythm 
that preclpltated eath. The discordance between the rhythm 
identified at the terminal event and the time course of the 
event is of critical importance. It was usually thought that 
v&Wicular tachycardii precipitates ventricular fibrillation, and 
that the latter evolves into either asystole or electromecbanical 
dissociation. Thus, there may be a lack of correlation between 
the first recorded rhythm and the rhythm at the onset of the 
terminal event. Ventricular ~Mlation is more likely to be 
recorded as the first documented rhy?hm when the recorZ!ing ;S 
obtained earliir ip the arrest (10) and when the victii is 
y-w WI. 
tttedmy.sDmeinvestigatorsbelievethatin- 
hospitalmortality,~ofthelengtboftimealteran 
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February 1996~43.1-42 
operation, is another time-relat-d end point to measure (35). 
This end point avoids the problem of failing to identifv 
complications following hospitz.: release, aithough such under- 
reporting should not he operative during clinical trials. Thus, in 
our classification, we, maintained the traditional definitions, 
even though concern has been raised about classification 
errors. For example,’ death due to trauma in a discharged 
patient less than 30 days postoperatively would be considered 
perioperative. However, our clas-ification scheme can be used 
to better characterize the circumstaxes of this perioperative 
death. 
Utility of pmposed classifkation scheme. The attractive- 
ness of our proposed classification of death in arrb, :hmia trials 
is that it incorporates the traditional time-based definitions of 
sudden death (see Table 3) with a more comprehensive 
description of circumstances of death, including the organ 
cause, whether the death was witnessed, the rhythm at the time 
of death and relation with the intervention in the trial, when 
the data are available (see Table 5). Furthermore, it recognizes 
the importance of the “circulatory status,” as proposed by 
Hinlde and Tbaler (17), when classifying cardiac deaths as 
sudden or simply as the final event on the continuum of a 
chronic and progressive disease process. The documentation 
field that classifies the death as being wimessed or not has 
components that include whether the death was actually 
observed and monitored. The scheme allows this information 
to be used when available, and again enables future studies to 
be correlated with older ones that have used these descriptors. 
Similarly, the additional data tabu!ation required with our 
scheme lends itself to future outcome analyses. For example, 
an excessive incidence- of death classified as pulse generator 
related may not be evident when only total mortality is 
assess& This information may be important to those consid- 
ering approval of a new device. However, classitication in the 
system relationship field requires special care because it is 
sometimes difficult to separate hardware malfunction attribut- 
able tc the device from judgment errors in programming. 
There is, unfortunately, no reference standard for the 
clas&cation of events in clinical trials. However. by using an 
events committee rather than relying on the judgment of 
individual investigators, the chance for bias and erron in the 
evaluation of clinical events is decreased. In the present study, 
the fact that the Events Committee changed the classitication 
offered by investigators 40% of the time attests to the magni- 
tude of the proklem. Events committee-s are commonly used in 
clinical investigation for this very reason (9.16,ZO). 
Although the proposed death classikation was developed 
and applied to trials that evaluated antiarrhythmia devkes, it is 
also applicable to interventions that use drugs, other devices 
(pacemakers for bradycardia, prosthetic valves, catheters for 
ablation) or new treatment modalities (such as new operative 
techniques). Fni example, the operake relation tkki could be 
arJ+edtodesaibethethneaxuseofeitherdtugorsurgM 
therapkThesystemrelatiollshipLldwouM,ofanase,~ 
,pereleml~todmg~bntcouldbe~to~ 
i l lMhkg~~~te~ilb)ationtedmiqueJ.FOreaam- 
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ple, if cardiac tamponade occurred ;nd resulted in death at the 
time of ablation, this would bc considered procedure related. 
Similarly, if death occurred in the periopxative phase after 
endocardial resection, this too would bc considered procedure 
related. Of course, when devices such as pulse generators or 
leads are not implanted, these fields would be not applicable. 
condusions. This report describes a classification scheme 
for deaths that occur in clinical trials testing the efficacy of 
antiarrhythmia therapies. The classitication scheme more fully 
describes the circumstances and mechanisms of death than 
previously proposed time-based and observation-based 
schemes. Furthermore, because of its categoric nature, thii 
scheme allows all trials, both old and new. to be compared. For 
these reasons, this classification scheme. or one similar to it. 
should be considered by any investigator launching a study of 
antiarrhythmia therapy. In the process of developing this 
classification scheme, we learned and modified our approach 
as case studies were evaluated. We fully expect that moditica- 
tions may be in order as technology evolves. 
We thank Cardii Pzamakers Inc., for mviting ilw: authors tu ww on tkir 
Event.5 Committe, -&ii revRvecl clinical data related In their devices and 
espetidly l&q A Hall. DVM, and Joseph 1. Lama for their support in thk 
endeavor. The manurript ic dedicated to tk memy of Frecteridr H. E+tein. 
MD.tigreatly influenced the primq authar’r thoqhtwn tber+&‘+ ‘!. n of 
death in epiamidogic studio and [he admiiistratioa of chnic~~ trials. 
442 EPSTEIN ET AI.. 
r‘LASSIFI~‘ATION OF DtAl II 
16. The Aspirin Myocardiai lnfnrctlon Study Rcseotch Group. The Aspirin 
Myocatdiai Infatctnm Study: linal tcwIt\. (‘itwh~iam IUXO:h? Suppl V:V- 
7Y-M. 
17. Hinklc LE, Thnlct HT. Chnical rlirwilia~1ion uf cwhdc dcathr, Cncul;dicm 
IYWZ;tJS:457-M, 
IX. Goklmin $ Fticdmun I.. Hurchinum R. el al. Timing. mechanism and 
chnicnl wuing of witnwscd dcuthr in pu~~myncwlkd inbtclion pabents. 
J Am (‘011 Cwlii)l 1984:3. I I I L-7 
1% MILIS Swdv Group. Multiccnter Inucr~iga1ion f the Limitation 111 Infarct 
Sic: desip.and melhod\ ol the clinicul Itial. Am Hc,sn A&w Mont*titph 
No. 1(X1, IY84. 
20. Byington RP, the Beta-Blocker Heait Attack Trial Rwwch Gloup. Bela- 
Blocker Heart Attack Trial: design, methods and baseline results. Conltol 
Clin Trials 19&13:382-437. 
21. Marcus FI, Cobb LA, Edwards JE. et al. Mechanism of death and prevalence 
of myucardird isehemic symptoms in the terminal event after acute myocar- 
dial infarction. Am J Catdiol 1988;61:8-IS. 
22. Kannel WB. Gagnon DR, Cwplples IA. Epidemiohlgy of sudden coronary 
&nth: population HI ti$k. Cnn J (‘atdwl IYYll;h:43Y- 44. 
23. Swcency MO, h&6\ AJ, Ebctly S. Inrlantancow cardiac death in the 
posrhtapi1al pwod allet acu~c myocatdial infarction. Am J Catdiol IYY)?: 
m137s-9. 
24. Epstcm AE. AVID necewty. PACI: lY%;lh:l77.3-5. 
25. Fxwt H. Endpoino and Itials: a maw of lift and dcalh. PACE IYY4; 17: 
IwY-HI. 
2h. Connolly SJ, “An AVID diwnt”. commeuaty. PACE 1YY4:17:1712-3. 
27. Kim SG, Fogovn RN. Furman S. cl al. Stnndrtdized repotting of ICD 
JACC Vol. 27, NIX 2 
I-chtuwy tY%42.3-4? 
palwor outcome: rhe repon of u Notlh Amwl ‘;n Society ol Pacing and 
filcc~t~~physiology Polily Cunktencc. Fehrua,, &III. l9u3. PACE lY93:16: 
Lwl-62. 
2X. Guutnieti T lavinc JH. GtiUhh LX. Veltti EP. When “sudden cardiac 
dca1h” is wt w sudden: lessons leatncd from the uutomutic implanlahle 
delibtdlattrt. Am Hern J IYx(I:I 15:2lH-7. 
?Y Aspirin Myocardial In~atction Swly Revzatch Group A twdomirrd, con- 
trolled ltial of aspirin in petsons tecovctcd Irom mywardial infarction. 
JAMA 1w):243:hni-~, 
It. Ec!ot Ii. Rogers R, Rubens A+ DC Gecst Ii. Classification of death in 
patvnls under antiatthythmic trcalmenl. PACE 1993;16:2250-4. 
31. Luu M. Stevenson WG, Stevenson LW, Baton K, Walden J. Diverse 
mechanisms of unexpected cardiac attest in advanced hean failure. Citcu- 
lation 1989;80%7.s-80. 
32. Cohn IN, Zicsche S. Rector TS. Interobserver diUerences in classification of
deaths in s1udies of heart failure [abstract). Circulation lYY3;1 Suppl 
I:I-Ml?. 
33. Pratt CM, Gtecnway PS. khwnfeld HH, Hihbcn ML, RriUcl JA. lmplica- 
lions of altetna1ive classilications of sudden c~lrdiac death: w pnqxxtivc 
analysis of l(N deaths In delihtilhmw trial\ [abwxt]. J Am (idI Cardiol 
lYY5:25:213A. 
34. Trwh DD. Thakut R. Ilollmann RG. Brooks IIL. Comparison of outcome 
of teruscilation 01 out-of-hospital cardiac “trrsl in persons younger and 
older than 70 yean ol age. Am J Catdiol IYxH;6l:I 120-2. 
3.5 Kitklin JW. Rattalt-Bayer FIG. Card& Sutgety: Morphology. Diagnmtic 
Ctilrti”, Natural Hs~ory, Techniques, Roubs, and Indicalions. 2nd cd. New 
York: Churchill Livingston:, 19%2SH. 
